Admera Health Becomes Certified Service Provider for Parse Biosciences
SEATTLE -- Parse Biosciences, known for its top-notch single cell sequencing solutions, is excited to welcome Admera Health as its latest Certified Service Provider. This partnership is set to empower researchers everywhere with enhanced access to advanced sequencing services.
Benefits of the Partnership
The collaboration between Admera Health and Parse Biosciences enhances the services available to researchers. Admera is renowned for its Next-Generation Sequencing (NGS) capabilities, which makes this joining of forces particularly beneficial. By incorporating Parse’s innovative single cell technology, Admera is now positioned to deliver even more robust and scalable solutions to its clients in various research fields.
Insights from Leadership
Dr. Yun Zhao, CEO of Admera Health, expressed enthusiasm about the partnership, stating, “We are honored to partner with Parse Biosciences as a Certified Service Provider. By integrating Parse’s innovative technology into our comprehensive suite of services, we empower researchers with scalable, high-quality single-cell solutions.” Undoubtedly, this partnership reflects Admera’s unwavering commitment to fostering scientific breakthroughs.
Expanding Access to Single Cell Solutions
According to Alex Rosenberg, co-founder and CEO of Parse Biosciences, welcoming Admera into the network furthers its mission to provide accessible solutions for scalable single cell research. He stated, “From the beginning, our mission at Parse has been to make scalable single cell solutions as accessible as possible. This partnership enables researchers to acquire high-quality data conveniently and confidently.”
About Admera Health
Admera Health stands out globally for its advanced genomic and bioinformatics support. They employ NGS expertise to serve a diverse clientele, including academic researchers and those in biotech and pharma industries. With a strong presence in New Jersey, Admera offers a comprehensive suite of services ranging from genomics to tailored bioinformatics solutions while maintaining high-quality standards.
Commitment to Quality in Research
Admera manages all samples with utmost care, ensuring they meet rigorous quality standards in a CLIA/CLEP-certified and CAP-accredited environment. This commitment to quality reflects their dedication to supporting diverse fields of research.
About Parse Biosciences
Founded to accelerate advancements in health and scientific research, Parse Biosciences is dedicated to making single cell sequencing accessible and simple. Their solutions are pivotal in driving scientific breakthroughs in areas such as cancer treatment and regenerative medicine.
Innovative Technology and Global Impact
Parse Biosciences builds upon transformative technology from the University of Washington and has successfully raised over $100 million. With a footprint in over 2,000 labs globally, their expanding product lineup includes advanced tools for data analysis, further showcasing their impact on the scientific community.
State-of-the-Art Facilities
Headquartered in Seattle, Parse recently opened a new state-of-the-art facility with 34,000 square feet of laboratory space designed to enhance its research and support capabilities. This new facility plays a crucial role in furthering their mission of advancing global research.
Frequently Asked Questions
What is Parse Biosciences?
Parse Biosciences is a life sciences company specializing in scalable solutions for single cell sequencing, driving advancements in various scientific fields.
What services does Admera Health provide?
Admera Health offers advanced genomic services through Next-Generation Sequencing, catering to academia, biotech, and pharmaceuticals.
How does the partnership benefit researchers?
This partnership enhances access to high-quality single cell technology, allowing scientists to conduct their projects with greater ease and confidence.
Where is Admera Health located?
Admera Health is based in New Jersey and provides services supported by high-quality standards.
What advancements can be expected from this partnership?
The collaboration aims to improve scalable single cell technologies and enrich scientific research efforts globally.
